Halberd Corporation Hires Auditor
Marketwired - Wed Nov 19, 4:15PM CST
Halberd Corporation (PINKSHEETS: HALB) Halberd Corporation has hired Zwick & Banyai, PLLC to audit the Company. The audit should start mid-December.
Halberd Signs Definitive Agreement for Medicinal Marijuana Farming Operation
Marketwired - Thu Oct 23, 8:45AM CDT
Halberd Corporation (PINKSHEETS: HALB) announces a definitive agreement with Gear International of Washington, Inc. The contract is part of a financing transaction for fixed payments from two different licensed medicinal marijuana farming operations. The properties involved are located in Michigan and Canada. These farms are currently operating and with Halberd's financing will be able to expand to be able to produce at a higher rate. The financing will be done in part through the issuance of shares of Halberd Corporation and other participants. The combined annual payments for both properties will be in excess of 3 million dollars annually. Revenue streams from this operation will commence in approximately 6-8 months. The 3 million dollars annually will continue indefinitely. This will give Halberd Corporation the cash flow to expand all of their operations even further. In addition, Halberd Corporation will receive shares from the four other participating companies at a market value in excess of 1 million dollars.
I-TAP, Inc.'s Founder and President Featured on Global Online CEO Conference
Marketwired - Wed Oct 22, 10:46AM CDT
Halberd Corporation (PINKSHEETS: HALB) subsidiary I-TAP, Inc. announced that John Osborne appeared on RedChip's Global Online CEO Conference to discuss the Company's prospects within the massive draft beer industry.
I-TAP, Inc. Enters Into Discussions With Potential Distribution Partner for Entry Into the South Korean Market
Marketwired - Thu Oct 09, 8:39AM CDT
Halberd Corporation (PINKSHEETS: HALB) subsidiary I-TAP, Inc. announced that the company has entered into discussions for the distribution and sale of I-TAP's proprietary electronic draft beer dispensing system with NexSol Technologies, Inc., a well-established firm headquartered in Seoul, Korea that has been conducting business there since 1980.
Anheuser-Busch InBev Budweiser to Begin Testing the I-TAP
Marketwire - Mon Oct 06, 7:15AM CDT
Halberd Corporation (PINKSHEETS: HALB) subsidiary I-TAP, Inc. announced that Anheuser-Busch InBev has scheduled a test of the I-TAP beer dispensing system at their research and development draught room in St. Louis.
Halberd Corporation and I-TAP, Inc. Announce CEO Interviews With Stock Legends Radio
Marketwire - Tue Sep 30, 7:48AM CDT
Halberd Corporation (PINKSHEETS: HALB) and its subsidiary I-TAP, Inc. the developer of the electronic I-TAP draft beer dispensing system today announced that Stock Legends recently conducted an audio interview with both Companies Chief Executive Officers, John Maddox and John Osborne.
I-TAP, Inc. Retains RedChip Companies, Inc. for Investor Relations
Marketwire - Thu Sep 25, 9:41AM CDT
Halberd Corporation (PINKSHEETS: HALB) subsidiary I-TAP, Inc. announced that the company has retained RedChip Companies, Inc. for investor relations.
I-TAP, Inc. Executes Financing Commitment Letter With Greg Norman's Great White Shark Opportunity Fund
Marketwire - Mon Sep 22, 7:52AM CDT
Halberd Corporation (PINKSHEETS: HALB) subsidiary I-TAP, Inc. announced that the company has entered into a conditional commitment letter with Greg Norman's Great White Shark Opportunity Fund to provide a $1 million credit facility to be used for expansion capital and to support I-TAP's sales efforts.
I-TAP, Inc. to Conduct Test Installation for Legends
Marketwire - Thu Sep 18, 7:23AM CDT
Halberd Corporation (PINKSHEETS: HALB) subsidiary I-TAP, Inc. has secured a test installation of the I-TAP beer dispensing system for Legends.
I-TAP, Inc. Receives Order From TD Garden, Home of the Boston Bruins and Celtics
Marketwire - Tue Sep 16, 7:40AM CDT
Halberd Corporation (PINKSHEETS: HALB) subsidiary I-TAP, Inc. announced that the company has received a purchase order from the Delaware North Companies for the installation of I-TAP's proprietary electronic draft beer dispensing systems at TD Garden in Boston, home of the Boston Bruins and Celtics.
Halberd Corporation Signs Definitive Agreement With I-TAP, Inc.
Marketwire - Mon Sep 15, 7:05AM CDT
Halberd Corporation (PINKSHEETS: HALB) executed a definitive agreement and has acquired control of Sarasota, Florida based I-TAP, Inc.
Halberd Corporation Enters Into Binding Term Sheet to Acquire Control of I-TAP, Inc.
Marketwire - Thu Sep 11, 7:30AM CDT
Halberd Corporation (PINKSHEETS: HALB) entered into a binding term sheet this week to enter into a definitive agreement to acquire control of Sarasota, Florida based I-TAP, Inc. The definitive agreement is expected to be signed in the next two weeks.
Halberd Corporation's New Subsidiary Aspyre.com Discusses Revenue Streams
PR Newswire - Tue Jul 22, 8:14AM CDT
Halberd Corporation (OTC Market: HALB) subsidiary Aspyre.com discusses the Company revenue sources.
Halberd Corporation Responds To False Press Release Issued By SMSW Corporation
PR Newswire - Tue Jul 08, 9:55AM CDT
Halberd Corporation (OTC Market: HALB) Halberd Corporation responds to the false press release issued by the plaintiffs (in three separate causes of action), including Marvin Katz and his companies, and Stephen Wilshinsky, his company and his mother. As a part of these plaintiffs' misleading financial claims, they are suing Halberd Corporation and the defendants for refusing to violate the law. Despite the plaintiffs' false claims, there has been no determination of liability. Indeed, the plaintiffs have lost every single motion in these cases which has a ruling. The California cases are as follows: CV 13-01412 BRO and 2:12-cv-10041 FMO (FFMx); the Nevada Case No. is A-14-697936-P. Each suit is frivolous. And Halberd Corporation will continue to vigorously defend each suit.
Emphysema - Pipeline Review, H2 2013 Research Report
M2 - Fri Feb 14, 2:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/5thttd/emphysema) has announced the addition of the "Emphysema - Pipeline Review, H2 2013" report to their offering. 'Emphysema - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Emphysema, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Emphysema. Scope - A snapshot of the global therapeutic scenario for Emphysema. - A review of the Emphysema products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Emphysema pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Key Topics Covered: Introduction Emphysema Overview Therapeutics Development Emphysema - Pipeline Products Glance Clinical Stage Products Early Stage Products Unknown Stage Products Icure Pharmaceutical Inc. Emphysema - Therapeutics Assessment Drug Profiles Alpha 1-Proteinase Inhibitor - Drug Profile HI-164OV - Drug Profile Lysine Acetylsalicylate - Drug Profile Alpha-1 Antitrypsin With rHuPH20 - Drug Profile Drug For Emphysema - Drug Profile Retinoic Acid Receptor Agonists - Drug Profile formoterol fumarate Patch - Drug Profile Featured News & Press Releases Companies Mentioned Protalix BioTherapeutics, Inc. Bioxyne Limited Kamada Ltd. Intrexon Corporation Medestea Research & Production S.p.A. Northern Therapeutics, Inc. Icure Pharmaceutical Inc. For more information visit http://www.researchandmarkets.com/research/5thttd/emphysema About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
XON: 26.19 (+0.67), KMDA: 3.57 (-0.03)